What is it about?

A large number of people are bitten by dogs, co-amoxiclav is an effective antibiotic treatment following a dog bite as it covers the most likely polymicrobial aerobic and anaerobic organisms that infect dog bite wounds (Staphylococci, Streptococci and Pasteurella).

Featured Image

Why is it important?

Pasteurella is the most infective pathogen in a dog bite so effective antibiotic treatment against it is essential to prevent a metastatic infection.

Perspectives

I hope that by writing this article it allows people to understand how the antibiotic co-amoxiclav is an effective first-line and prophylactic oral antibiotic treatment for dog bites. This article explores the normal physiology of human skin including the pathophysiology after sustaining a dog bite. It also examines the pharmacology of co-amoxiclav including critically reviewing the current evidence for the effectiveness of its use in this field. I very much hope that you find this article informative and thought provoking.

Marc Gildas Thomas
Swansea University

Read the Original

This page is a summary of: Use of co-amoxiclav for the treatment of dog bites, Journal of Paramedic Practice, May 2020, Mark Allen Group, DOI: 10.12968/jpar.2020.12.5.cpd1.
You can read the full text:

Read

Contributors

The following have contributed to this page